S O Dima1,2, T Dumitrascu1, C Pechianu2,3, R T Grigorie1, V Brasoveanu1, A Sorop2, I Lupescu4, R Purnichescu-Purtan5, A Croitoru1,6, N Bacalbasa1,2, A Tanase6, D R Tomescu1, V Herlea3,6, I Popescu1,6. 1. Fundeni Clinical Institute - Center of Digestive Diseases and Liver Transplantation - Bucharest, Romania. 2. Fundeni Clinical Institute - Center of Excellence in Translational Medicine - Bucharest, Romania. 3. Fundeni Clinical Institute - Department of Pathology - Bucharest, Romania. 4. Fundeni Clinical Institute - Department of Radiology and Medical Imaging - Bucharest, Romania. 5. Fundeni Clinical Institute - University Politehnica of Bucharest, Departament of Mathematical Methods and Models, Bucharest, Romania. 6. Fundeni Clinical Institute - "Titu Maiorescu" University - "Acad. Nicolae Cajal" Institute of Medical Scientific Research, Bucharest, Romania.
Abstract
CONTEXT: Pancreatic neuroendocrine tumours (PanNETs) are rare pancreatic neoplasms. PanNETs can be treated by multimodal approach including surgery, locoregional and systemic therapy. OBJECTIVE: The aim of the present study is to evaluate predictive factors of overall survival in patients with PanNETs surgically treated at a single center. SUBJECTS AND METHODS: The study group consisted of 120 patients with PanNETs who had undergone surgery at the Center of Digestive Diseases and Liver Transplantation of Fundeni Clinical Institute, Bucharest, Romania. Surgical resection of the primary tumor was performed in 110 patients. RESULTS: Tumor size > 2 cm (p=0.048) (90% CI) lymph node involvement (p=0.048), ENET grade (p<0.001), distant metastases (p<0.001), Ki 67 index (<2%, 2-5%, 5-10%, 10-20%, >20%) (p<0.001) were identified as significant prognostic factors for OS on univariate analysis. Using multivariate Cox proportional regression model we found that distant metastases and Ki 67 index were independent risk factors for the survival outcome. CONCLUSIONS: Surgery with curative intent should be considered in all cases if clinically appropriate and technically feasible. High grade (Ki67 index ≥10%) tumours were associated with a 2- fold increase in risk of death as compared to those with a Ki67 <10%.
CONTEXT: Pancreatic neuroendocrine tumours (PanNETs) are rare pancreatic neoplasms. PanNETs can be treated by multimodal approach including surgery, locoregional and systemic therapy. OBJECTIVE: The aim of the present study is to evaluate predictive factors of overall survival in patients with PanNETs surgically treated at a single center. SUBJECTS AND METHODS: The study group consisted of 120 patients with PanNETs who had undergone surgery at the Center of Digestive Diseases and Liver Transplantation of Fundeni Clinical Institute, Bucharest, Romania. Surgical resection of the primary tumor was performed in 110 patients. RESULTS: Tumor size > 2 cm (p=0.048) (90% CI) lymph node involvement (p=0.048), ENET grade (p<0.001), distant metastases (p<0.001), Ki 67 index (<2%, 2-5%, 5-10%, 10-20%, >20%) (p<0.001) were identified as significant prognostic factors for OS on univariate analysis. Using multivariate Cox proportional regression model we found that distant metastases and Ki 67 index were independent risk factors for the survival outcome. CONCLUSIONS: Surgery with curative intent should be considered in all cases if clinically appropriate and technically feasible. High grade (Ki67 index ≥10%) tumours were associated with a 2- fold increase in risk of death as compared to those with a Ki67 <10%.
Entities:
Keywords:
neuroendocrine; pancreatic; prognostic factors; surgery
Authors: Quyen D Chu; Hank C Hill; Harold O Douglass; Deborah Driscoll; Judy L Smith; Hector R Nava; John F Gibbs Journal: Ann Surg Oncol Date: 2002-11 Impact factor: 5.344
Authors: Steven N Hochwald; Sui Zee; Kevin C Conlon; Roberto Colleoni; Otway Louie; Murray F Brennan; David S Klimstra Journal: J Clin Oncol Date: 2002-06-01 Impact factor: 44.544
Authors: Megan Dann Fesinmeyer; Melissa A Austin; Christopher I Li; Anneclaire J De Roos; Deborah J Bowen Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-07 Impact factor: 4.254
Authors: Henning Dralle; Sabine L Krohn; Wolfram Karges; Bernhard O Boehm; Michael Brauckhoff; Oliver Gimm Journal: World J Surg Date: 2004-11-11 Impact factor: 3.352
Authors: Vikram Deshpande; Carlos Fernandez-del Castillo; Alona Muzikansky; Anita Deshpande; Lawrence Zukerberg; Andrew L Warshaw; Gregory Y Lauwers Journal: Am J Surg Pathol Date: 2004-09 Impact factor: 6.394
Authors: G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann Journal: Virchows Arch Date: 2006-09-12 Impact factor: 4.064
Authors: A Croitoru; I Dinu; V Herlea; G Becheanu; M Grasu; I Lupescu; S O Dima; F Buica; T Dumitrascu; C Lungulescu; V M Croitoru; A Tanase; S M Negru; I M Gramaticu Journal: Acta Endocrinol (Buchar) Date: 2019 Jul-Sep Impact factor: 0.877
Authors: M Tarquini; M R Ambrosio; M Albertelli; P B de Souza; R Gafà; I Gagliardi; A Carnevale; P Franceschetti; M C Zatelli Journal: J Endocrinol Invest Date: 2020-09-06 Impact factor: 4.256